Cost-Effectiveness of Continuous Glucose Monitoring With Remote Patient Monitoring in Pediatric Patients With Newly Diagnosed Type 1 Diabetes in the U.S.
Diabetes Care · 01.05.2026 · 49 (5) · 889-897
DOI: 10.2337/dc25-2825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 25.03.2026. Verfasst von Paul Dupenloup und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Management Science and Engineering, Stanford University, Stanford, CA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Blood Glucose Self-Monitoring. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Stanford School of Medicine Research Office, Stanford HAI, The Helmsley Charitable Trust.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE The use of continuous glucose monitoring (CGM) with remote patient monitoring (RPM) continues to grow. We evaluated the cost-effectiveness of CGM with RPM compared with self-monitoring of blood glucose (SMBG) and CGM alone. RESEARCH DESIGN AND METHODS We simulated type 1 diabetes progression with a Markov model in 5-year-old patients over a 20-year, 50-year, and lifetime horizon. We tracked diabetic ketoacidosis (DKA), severe hypoglycemia (SH), and seven chronic complications: retinopathy, neuropathy, nephropathy, cardiovascular disease, end-stage renal disease, lower-extremity amputation, and blindness. We compared three interventions: SMBG, CGM, and CGM with RPM. Efficacy estimates were derived from meta-analyses of pediatric CGM studies and the results of the Teamwork, Targets, Technology, and Tight Glycemia Study (4T Study 1). We evaluated quality-adjusted life years (QALYs) and health care costs (2022 U.S. dollars) discounted at 3% annually. We performed extensive sensitivity analyses. RESULTS Compared with SMBG, CGM increased QALYs by 0.09 and costs by $8,900 over 20 years; CGM with RPM increased QALYs by 0.37, and costs by $10,300. CGM with RPM yielded more QALYs at a lower incremental cost-effectiveness ratio compared with CGM ($27,400/QALY vs. $103,700/QALY, respectively). Results were robust across sensitivity analyses and time horizons. CGM with RPM remained cost-effective when achieving at least 30% of 4T’s clinical efficacy. CONCLUSIONS CGM with RPM delivers superior health outcomes compared with SMBG and CGM and is likely cost-effective for patients with newly diagnosed type 1 diabetes. Despite higher intervention costs, CGM with RPM can reduce complications costs and generate net health care savings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Management Science and Engineering, Stanford University, Stanford, CA.
- Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University, Stanford, CA.
- Stanford Diabetes Research Center, Stanford University, Stanford, CA.
- Clinical Excellence Research Center, Stanford University, Stanford, CA.
- Division of Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA.
ORCID-Profile: Paul Dupenloup
Förderung
- Stanford School of Medicine Research Office
- Stanford HAI
- The Helmsley Charitable Trust
- NIDDK NIH HHS
- Stanford Maternal & Child Health Research Institute
- NCRR NIH HHS
- Lucile Packard Children's Hospital Auxiliaries Endowment
- NCATS NIH HHS
Zitieren
APA
Dupenloup, P., Chen, Y., Prahalad, P., Johari, R., Addala, A., Zaharieva, D. P., Lee, M. Y., Maahs, D. M., Scheinker, D., Brandeau, M. L., & 4T Research Team* (2026). Cost-Effectiveness of Continuous Glucose Monitoring With Remote Patient Monitoring in Pediatric Patients With Newly Diagnosed Type 1 Diabetes in the U.S. Diabetes Care, 49(5), 889-897. https://doi.org/10.2337/dc25-2825
Vancouver
Dupenloup P, Chen Y, Prahalad P, Johari R, Addala A, Zaharieva DP, et al. Cost-Effectiveness of Continuous Glucose Monitoring With Remote Patient Monitoring in Pediatric Patients With Newly Diagnosed Type 1 Diabetes in the U.S. Diabetes Care. 2026;49(5):889-897. doi:10.2337/dc25-2825
BibTeX
@article{Dupenloup2026,
author = {Dupenloup, Paul and Chen, Yupeng and Prahalad, Priya and Johari, Ramesh and Addala, Ananta and Zaharieva, Dessi P and Lee, Ming Yeh and Maahs, David M and Scheinker, David and Brandeau, Margaret L and 4T Research Team*, 4T Research Team*},
title = {Cost-Effectiveness of Continuous Glucose Monitoring With Remote Patient Monitoring in Pediatric Patients With Newly Diagnosed Type 1 Diabetes in the U.S},
journal = {Diabetes Care},
year = {2026},
volume = {49},
number = {5},
pages = {889--897},
doi = {10.2337/dc25-2825}
}
EUVIMED